Insiders · ASND

Jay Donovan Wu

EVP & President US Market at Ascendis Pharma A/S (ASND) since March 2026

Jay Donovan Wu has filed 1 insider report with the SEC since March 2026, as EVP & President US Market at Ascendis Pharma A/S (ASND). The latest filing, on March 18, 2026, is a Form 3: Jay Donovan Wu became an insider at Ascendis Pharma A/S (ASND).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where Jay Donovan Wu is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Ascendis Pharma A/S logo
ASND
Ascendis Pharma A/S
EVP & President US Marketsince March 20261,068$252.73Mar 18, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Other insiders at the same companies

Questions about Jay Donovan Wu

What is Jay Donovan Wu's role at Ascendis Pharma A/S?
Jay Donovan Wu reports to the SEC as EVP & President US Market at Ascendis Pharma A/S (ASND), according to the latest filing on March 18, 2026.
How many shares does Jay Donovan Wu own?
After the latest filing that states it, Jay Donovan Wu directly owned 1,068 shares of Ascendis Pharma A/S (ASND). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jay Donovan Wu bought or sold stock recently?
No open-market purchases or sales by Jay Donovan Wu are on file.
How do I get alerts when Jay Donovan Wu files?
Follow Jay Donovan Wu on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jay Donovan Wu (SEC CIK 0002079744). Totals count each trade once, skipping amendments whose original is on file, from Mar 18, 2026 on. View on SEC EDGAR · Get this as JSON